Nicotinamide: a potential addition to the anti-psoriatic weaponry
NAMAZI
FASEB J. 2003;17:1377-1379.
ABSTRACT
| FULL TEXT
Consensus Statement on the Use of Intravenous Immunoglobulin Therapy in the Treatment of Autoimmune Mucocutaneous Blistering Diseases
Ahmed and Dahl
Arch Dermatol 2003;139:1051-1059.
ABSTRACT
| FULL TEXT
Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline
Robertson et al.
Ann Rheum Dis 2003;62:267-269.
ABSTRACT
| FULL TEXT
Minocycline-Induced Hyperpigmentation in Patients With Pemphigus and Pemphigoid
Ozog et al.
Arch Dermatol 2000;136:1133-1138.
ABSTRACT
| FULL TEXT
Bullous Pemphigoid: The Latest in Diagnosis, Prognosis, and Therapy
Korman
Arch Dermatol 1998;134:1137-1141.
FULL TEXT
Vesicobullous Lesions in a Child
Nyul et al.
Arch Dermatol 1997;133:779-780.
ABSTRACT
Management of Acquired Bullous Skin Diseases
Fine
NEJM 1995;333:1475-1484.
FULL TEXT
Is the Combination of Tetracycline and Nicotinamide Therapy Alone Effective in Pemphigus?
Alpsoy et al.
Arch Dermatol 1995;131:1339-1340.
ABSTRACT
Nicotinamide and Tetracycline Therapy of Bullous Pemphigoid
Fivenson et al.
Arch Dermatol 1994;130:753-758.
ABSTRACT
Dermatology and the Evolution of Therapies to Control Inflammatory Tissue Injury
Lorincz
Arch Dermatol 1994;130:781-782.
ABSTRACT
Controlled Trial of Azathioprine and Plasma Exchange in Addition to Prednisolone in the Treatment of Bullous Pemphigoid
Guillaume et al.
Arch Dermatol 1993;129:49-53.
ABSTRACT
A Peculiar Case of Linear IgA Bullous Dermatosis
Fuligni et al.
Arch Dermatol 1991;127:126-127.
ABSTRACT